Capture réglementaire en temps de pandémie by Samira Guennif

Subjects: “…pharmaceutical industry…”
Get full text

Private Label: o potencial impacto no mercado de medicamentos no Brasil by Ronaldo Raemy Rangel, Luan Vinicius Bernardelli, Paulo Rogério Alves Brene

Subjects: “…pharmaceutical industry…”
Get full text

Medical students’ exposure to and attitudes towards product promotion and incentives from the pharmaceutical industry in 2019: a national cross-sectional study in France by Maxime Esvan, Benjamin Bastian, Martin Molina, Adeline Boëffard

“…Objectives To measure medical students’ exposure to pharmaceutical product promotion and incentives nationwide, and to evaluate students’ attitudes towards the pharmaceutical industry, access to education on promotional strategies and knowledge of institutional policies about drug company-student relationships.Design Cross-sectional survey based on a 48-item anonymous questionnaire.Setting All 37 French medical schools, from March to April 2019.Participants French medical students in their 4th year of study and beyond, having studied exclusively in France.Main outcome measure Cumulative frequency of students’ exposure to pharmaceutical product promotion and incentives.Secondary outcome measures Exposure within the last 6 months, attitudes regarding interactions with the industry, access to education on pharmaceutical product promotion and incentives and knowledge of institutional policies.Results 6280 responses were analysed (10.4% out of a total of 60 550 eligible students). 5992 students (96.3% poststratification, 99% CI (96.1% to 96.5%)) had already been exposed to pharmaceutical product promotion and incentives and 4650 (78.1%, 99% CI (77.7% to 78.6%)) within the last 6 months. 5140 students (85.4%, 99% CI (84.8% to 85.8%)) had met a pharmaceutical representative. …”
Get full text

Identifying and ranking the circular supply chain implementation challenges using pythagorean fuzzy SWARA approach (case of study: pharmaceutical industry of Guilan province) by Samaneh Rash, Mostafa Ebrahimpour Azbari, Mohammad Rahim Ramazanian

“…We used the proposed method in the pharmaceutical industry of the Guilan province.Findings: In the final results of the research, Strategic Challenges (SCs) and operational and environmental challenges are prioritized.Originality/Value: This research serves as a step for industry practitioners to efficiently and effectively adopt a CSC.…”
Get full text

La construction des catégories diagnostiques de maladie mentale by Cédric Brun, Steeves Demazeux, Pierangelo Di Vittorio, François Gonon, Philippe Gorry, Jan Peter Konsman, Fanny Lung, Yannick Lung, Michel Minard, Matthieu Montalban, Nicole Rumeau, Andy Smith

Subjects: Get full text

Médicaments génériques : pivot de la reconstruction de l’industrie pharmaceutique by Philippe Abecassis, Nathalie Coutinet

Subjects: Get full text

Ranking of companies in generating operating cash flows based on data envelopment analysis by Leila Negahban, Bahman Banimahd, Seyed Hosseini, Azam Shokri Cheshmeh Sabzi

Subjects: Get full text

Internal Audit Aspects of Companies' Sustainability Reporting by Antonella Maria TIMIS, Aurelia STEFANESCU

Subjects: Get full text

Information Technology Framework for Pharmaceutical Supply Chain Demand Management: a Brazilian Case Study by Pedro Domingos Antoniolli

Subjects: Get full text

Tactical measures set to improve the import substitution process in the field of Russian pharmaceuticals by L. V. Orlova, P. V. Zobov

Subjects: Get full text

TRENDS OF THE DEVELOPMENT OF HIGHER PHARMACEUTICAL EDUCATION by Natalia S. Golikova, Vadim V. Tarasov, Ivan I. Krasnyuk, Elena F. Savosina

“…The dynamic development of the pharmaceutical industry in the Russian Federation is closely connected with training of qualified personnel, which in turn requires modernization of the education programs of higher professional education. …”
Get full text

Legal Basis of State Support for Creating Innovative Medicinal Products by S. V. Vasyliev

“…A detailed characteristic of the existing means of the state support for scientific research in the pharmaceutical industry is provided. The state supports innovations by establishing tax incentives for research institutions and providing funding for some innovative projects. …”
Get full text

Simulation Modeling of a Pharmaceutical Tablet Manufacturing Process via Wet Granulation by Zhengsong Wang, Zhen Pan, Dakuo He, Jiahui Shi, Shouxin Sun, Yue Hou

“…The pharmaceutical tablet manufacturing process (PTMP) via wet granulation holds a critical position in pharmaceutical industry. The interest in integrating mechanistic process modeling into the pharmaceutical development has been increased because simulation model is a prerequisite for process design, analysis, control, and optimization. …”
Get full text

Meta-analysis of RNA-Seq datasets allows a better understanding of P. tricornutum cellular biology, a requirement to improve the production of Biologics by Isabelle Boulogne, Charlotte Toustou, Muriel Bardor

“…Abstract The marine diatom Phaeodactylum tricornutum is currently used for various industrial applications, including the pharmaceutical industry as a cost-effective cell biofactory to produce Biologics. …”
Get full text

Integrating Model‐Informed Drug Development With AI: A Synergistic Approach to Accelerating Pharmaceutical Innovation by Karthik Raman, Rukmini Kumar, Cynthia J. Musante, Subha Madhavan

“…ABSTRACT The pharmaceutical industry constantly strives to improve drug development processes to reduce costs, increase efficiencies, and enhance therapeutic outcomes for patients. …”
Get full text

The Convergence of Nanotechnology, Biotechnology and Cancer Medicine in the Fourth Industrial Revolution by Steven Mufamadi, Zamanzima Mazibuko

“… Medical technologies of the fourth industrial revolution (Industry 4.0), such as nanotechnology, biotechnology, artificial  intelligence (AI), 3D printing and advanced materials are already transforming medical technology and the pharmaceutical industry by offering accurate diagnoses, targeting therapies with fewer side effects, and providing better medical imaging and personalised medicine. …”
Get full text

Clinical Trials in Chronic Liver Disease - What Do They Achieve? by Jenny Heathcote

“…The past 30 years have seen rapid growth in the number of clinical trials in liver disease; due mostly to effective drug discovery programs by the pharmaceutical industry. The advantages associated with therapeutic trials in chronic liver disease, or any other disease for that matter, go far beyond potential benefit to the individual patient, other beneficiaries include the treating physician, the sponsoring agency and their investors, the institution/university and the general public. …”
Get full text

STUDY ON KINEMATIC ANALYSIS OF CHAIN TRANSMISSIONS by Sabin Cristinel DIMULESCU, M. WETTERNEK

“…They are easy to maintain, have a long service life and can be used for various applications, such as: industrial conveyors, military applications, the pharmaceutical industry and the automotive industry.…”
Get full text

Cannabinoids for the Treatment of Pain: An Update on Recent Clinical Trials by Mark Ware, Pierre Beaulieu

“…Cannabinoid products are becoming available for research and clinical use, and pharmaceutical industry interest in the potential for cannabinoids in therapeutics is also gaining momentum. …”
Get full text